Risk Factors for Tumor Lysis Syndrome (TLS) In Patients with Chronic Lymphocytic Leukemia (CLL) Treated with the Cyclin Dependent Kinase Inhibitor, Flavopiridol

被引：0
|
作者：
Blum, Kristie A. [1 ]
Ruppert, Amy S. [1 ]
Woyach, Jennifer A. [1 ]
Jones, Jeffrey A. [1 ]
Andritsos, Leslie [1 ]
Flynn, Joseph M. [1 ]
Rovin, Brad [1 ]
Villalona-Calero, Miguel [1 ]
Ji, Jia [1 ]
Phelps, Mitchell [1 ]
Johnson, Amy J. [1 ]
Greyer, Michael R. [1 ]
Byrd, John C. [1 ]
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：596 / 597
页数：2
相关论文
共 50 条
  • [21] Risk Mitigation of Tumor Lysis Syndrome in Off Label Lenalidomide Treated CLL Patients: Effectiveness of the TLS Educational Outreach Program
    Weiss, L.
    Gary, D.
    Freeman, J.
    Delap, R.
    Knight, R.
    Zeldis, J.
    DRUG SAFETY, 2013, 36 (09) : 882 - 883
  • [22] Cyclin-dependent kinase inhibitor Roscovitine induces apoptosis in chronic lymphocytic leukemia cells
    I N Hahntow
    F Schneller
    M Oelsner
    K Weick
    I Ringshausen
    F Fend
    C Peschel
    T Decker
    Leukemia, 2004, 18 : 747 - 755
  • [23] Cyclin-dependent kinase inhibitor Roscovitine induces apoptosis in chronic lymphocytic leukemia cells
    Hahntow, IN
    Schneller, F
    Oelsner, M
    Weick, K
    Ringshausen, I
    Fend, F
    Peschel, C
    Decker, T
    LEUKEMIA, 2004, 18 (04) : 747 - 755
  • [24] Spontaneous tumor lysis syndrome in a patient of chronic lymphocytic leukemia
    Gogia, Ajay
    Raina, Vinod
    Iqbal, Nida
    Murugan, Vijaya
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2014, 35 (01) : 120 - 120
  • [25] PHASE I STUDY OF THE CYCLIN-DEPENDENT KINASE (CDK) INHIBITOR DINACICLIB (SCH 727965) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
    Jones, J.
    Flynn, J.
    Andritsos, L.
    Johnson, A.
    Blum, K.
    Wiley, E.
    Small, K.
    Grever, M.
    Graef, T.
    Bannerji, R.
    Byrd, J.
    HAEMATOLOGICA, 2012, 97 : 219 - 219
  • [26] Cyclin-dependent kinase inhibitors for the treatment of chronic lymphocytic leukemia
    Blachly, James S.
    Byrd, John C.
    Grever, Michael
    SEMINARS IN ONCOLOGY, 2016, 43 (02) : 265 - 273
  • [27] FLUDARABINE CAUSING TUMOR LYSIS SYNDROME IN CHRONIC LYMPHOCYTIC-LEUKEMIA
    MULLIGAN, SP
    DEAN, MG
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1994, 24 (04): : 406 - 407
  • [28] Mutational analysis of the cyclin-dependent kinase inhibitor p27 in chronic B-cell lymphocytic leukemia (B-CLL).
    Pappa, V
    Douka, E
    Kontsioti, F
    Economopoulos, T
    Bakiri, M
    Dervenoulas, J
    Tsirigotis, P
    Mantzios, G
    Papageorgiou, E
    Raptis, S
    BLOOD, 2000, 96 (11) : 750A - 750A
  • [29] Radiation-Induced Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia
    Alkan, Ali
    Kutuk, Tugce
    Karci, Ebru
    Yasar, Arzu
    Hicsonmez, Ayse
    Utkan, Gungor
    TURKISH JOURNAL OF HEMATOLOGY, 2016, 33 (03) : 248 - 250
  • [30] Pneumatic tube "pseudo tumor lysis syndrome" in chronic lymphocytic leukemia
    Chawla, Neha R.
    Shapiro, Joel
    Sham, Ronald L.
    AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (09) : 613 - 614
12345